Amelioration of Coagulation Disorders and Inflammation by Hydrogen-Rich Solution Reduces Intestinal Ischemia/Reperfusion Injury in Rats through NF-B/NLRP3 Pathway.
Yang L, Guo Y, Fan X, Chen Y, Yang B, Liu KX, Zhou J · Mediators of inflammation · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
Molecular hydrogen produced a favorable primary result in this animal study, supporting further research into its potential for ischemia-reperfusion injury.
Hydrogen ischemia-reperfusion study 2020 yang: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This animal study examined Amelioration of Coagulation Disorders and Inflammation by Hydrogen-Rich Solution Reduces Intestinal Ischemia/Reperfusion Injury in Rats through NF-B/NLRP3 Pathway. The abstract describes Rat model; hydrogen delivered as injected or infused hydrogen. The results showed that HRS improved the survival rate and alleviated serum diamine oxidase activities, intestinal injury, edema, and apoptosis (programmed cell death).
Publication: Yang L, Guo Y, Fan X, Chen Y, Yang B, Liu KX, Zhou J, Mediators of inflammation, 2020.
What the researchers studied
The purpose of this study was to explore whether hydrogen-rich solution (HRS) could attenuate coagulation disorders and inflammation to improve intestinal injury and poor…
What effects did molecular hydrogen have?
Observed hydrogen effects: The results showed that HRS improved the survival rate and alleviated serum diamine oxidase activities, intestinal injury, edema, and apoptosis (programmed cell death). Intestinal ischemia/reperfusion (I/R) injury often causes inflammatory responses and coagulation disorders, which is further promoting the deterioration of the disease.
Why these findings matter
The result supports the biological and therapeutic potential of injected or infused hydrogen for ischemia-reperfusion injury. It shows that hydrogen affected meaningful outcomes in an animal model, but it does not prove that the same benefit will occur in people.
How strong is this evidence?
This is preclinical animal evidence. It can show biological effects in a whole living system, but human effectiveness and dosing still require clinical trials.
Technical study details
- Publication type: Animal study
- Evidence type: Preclinical animal evidence
- Research model or population: Rat model
- Hydrogen method: Injected or infused hydrogen
Limitations and safety
Important limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.